Pulse Biosciences (PLSE) had the highest return between March 6, 2023 and April 30, 2023 by a small-cap US stock, returning 136.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Pulse Biosciences (PLSE) | 3/6/2023 - 4/30/2023 | 136.76% |
Immuneering (IMRX) | 3/6/2023 - 4/30/2023 | 114.87% |
Eyepoint Pharmaceuticals (EYPT) | 3/6/2023 - 4/30/2023 | 90.3% |
Neurogene (NGNE) | 3/6/2023 - 4/30/2023 | 82.53% |
Sophia Genetics (SOPH) | 3/6/2023 - 4/30/2023 | 74.73% |
Aquestive Therapeutics (AQST) | 3/6/2023 - 4/30/2023 | 71.79% |
Arlo Technologies (ARLO) | 3/6/2023 - 4/30/2023 | 71.73% |
Mercurity Fintech Holding Inc ADR (MFH) | 3/6/2023 - 4/30/2023 | 69.33% |
ThredUp (TDUP) | 3/6/2023 - 4/30/2023 | 66.04% |
Xeris Pharmaceuticals (XERS) | 3/6/2023 - 4/30/2023 | 63.77% |
Bit Digital (BTBT) | 3/6/2023 - 4/30/2023 | 63.64% |
Burford Capital (BUR) | 3/6/2023 - 4/30/2023 | 61.06% |
American Coastal Insurance (ACIC) | 3/6/2023 - 4/30/2023 | 58.85% |
Crawford (CRD.A) | 3/6/2023 - 4/30/2023 | 54.62% |
Corvus Pharmaceuticals (CRVS) | 3/6/2023 - 4/30/2023 | 52.11% |
Omeros (OMER) | 3/6/2023 - 4/30/2023 | 51.04% |
Mistras (MG) | 3/6/2023 - 4/30/2023 | 50.65% |
X4 Pharmaceuticals (XFOR) | 3/6/2023 - 4/30/2023 | 50.31% |
Crawford (CRD.B) | 3/6/2023 - 4/30/2023 | 50.09% |
Amprius Technologies (AMPX) | 3/6/2023 - 4/30/2023 | 48.42% |
Trevi Therapeutics (TRVI) | 3/6/2023 - 4/30/2023 | 47.01% |
Jiayin (JFIN) | 3/6/2023 - 4/30/2023 | 44.33% |
Maui Land & Pineapple (MLP) | 3/6/2023 - 4/30/2023 | 38.78% |
Beazer Homes USA (BZH) | 3/6/2023 - 4/30/2023 | 37.84% |
Cimpress (CMPR) | 3/6/2023 - 4/30/2023 | 37.4% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
